Inactive Instrument

Beximco Pharmaceuticals Limited Stock Dhaka S.E.

Equities

Pharmaceuticals

End-of-day quote Dhaka S.E.
- BDT - Intraday chart for Beximco Pharmaceuticals Limited
Sales 2024 * 44.51B 379M Sales 2025 * 50.42B 429M Capitalization 53.8B 458M
Net income 2024 * 5.25B 44.7M Net income 2025 * 6.24B 53.15M EV / Sales 2024 * 1.34 x
Net Debt 2024 * 5.96B 50.7M Net Debt 2025 * 878M 7.48M EV / Sales 2025 * 1.08 x
P/E ratio 2024 *
9.8 x
P/E ratio 2025 *
7.99 x
Employees -
Yield 2024 *
3.45%
Yield 2025 *
4.36%
Free-Float 76.68%
More Fundamentals * Assessed data
Managers TitleAgeSince
Director of Finance/CFO 61 89-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Founder - 75-12-31
Founder - 75-12-31
Chief Executive Officer - 84-12-31
More insiders
Beximco Pharmaceuticals Limited is a Bangladesh-based company which is a manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories. It offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable and Large Volume Intravenous Fluids. Besides formulation products, the Company also manufactures APIs and renders contract manufacturing services to other companies. Products of the Company are sold in domestic and international markets. The subsidiaries of the Company include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), Beximco Pharma API Limited (BPAL).
More about the company